Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Assets (2020 - 2025)

Historic Assets for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to $10.1 million.

  • Rani Therapeutics Holdings' Assets fell 7671.34% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 7671.34%. This contributed to the annual value of $36.6 million for FY2024, which is 3674.63% down from last year.
  • According to the latest figures from Q3 2025, Rani Therapeutics Holdings' Assets is $10.1 million, which was down 7671.34% from $16.9 million recorded in Q2 2025.
  • Over the past 5 years, Rani Therapeutics Holdings' Assets peaked at $137.0 million during Q3 2021, and registered a low of $10.1 million during Q3 2025.
  • Its 5-year average for Assets is $72.8 million, with a median of $73.9 million in 2021.
  • As far as peak fluctuations go, Rani Therapeutics Holdings' Assets soared by 5640.24% in 2021, and later plummeted by 7671.34% in 2025.
  • Over the past 5 years, Rani Therapeutics Holdings' Assets (Quarter) stood at $124.2 million in 2021, then decreased by 13.03% to $108.0 million in 2022, then plummeted by 46.39% to $57.9 million in 2023, then crashed by 36.75% to $36.6 million in 2024, then plummeted by 72.32% to $10.1 million in 2025.
  • Its Assets was $10.1 million in Q3 2025, compared to $16.9 million in Q2 2025 and $24.1 million in Q1 2025.